SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001358403-17-000149
Filing Date
2017-08-08
Accepted
2017-08-08 16:08:56
Documents
3
Period of Report
2017-08-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a8-kearningsreleaseqtr22017.htm 8-K 34552
2 EXHIBIT 99.1 qtr2-2017earningsreleaseex.htm EX-99.1 164472
3 BLCM LOGO qtr22017a01.jpg GRAPHIC 27677
  Complete submission text file 0001358403-17-000149.txt   238505
Mailing Address 2130 WEST HOLCOMBE BOULEVARD SUITE 800 HOUSTON TX 77030
Business Address 2130 WEST HOLCOMBE BOULEVARD SUITE 800 HOUSTON TX 77030 (832) 384-1100
BELLICUM PHARMACEUTICALS, INC (Filer) CIK: 0001358403 (see all company filings)

IRS No.: 201450200 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36783 | Film No.: 171014794
SIC: 2834 Pharmaceutical Preparations